- Mynd Life Sciences (MYND) Chief Scientific Officer, Dr. Wilf Jefferies, celebrates a professional milestone
- Dr. Wilfred Jefferies has been inducted as a Fellow of the National Academy of Inventors
- As for The National Academy of Inventors, it is a non-profit organization with the mission to recognize and encourage academic invention
- Dr. Jefferies is investigating novel biomarkers for monitoring the activity of psilocybin and psilocybin analogs
- Mynd Life Sciences Inc. (MYND) is in the grey, trading at C$0.06 at 11:34 am EST
Dr. Wilfred Jefferies, Chief Scientific Officer at Mynd Life Sciences (MYND), has been inducted as a Fellow of the National Academy of Inventors.
Globally, the NAI Fellows Program represents more than 300 universities and research institutes. Gaining this status is one of the most significant professional distinctions for an academic inventor, with more than 1,500 fellows worldwide.
Dr. Jefferies has been recognized for his many research discoveries and inventions in the field of biomedical research. The induction ceremony took place in Phoenix, Arizona.
As for The National Academy of Inventors, it is a non-profit organization with the mission to recognize and encourage academic invention.
The NAI Fellows Program highlights academic inventors who have created or facilitated outstanding inventions that have positively impacted society.
Dr. Jefferies is investigating novel biomarkers for monitoring the activity of psilocybin and psilocybin analogs and treatments for neuroinflammatory disorders using psilocybin and psilocybin analogs.
Since the inception of the National Academy of Inventors Fellow program, 1,567 Fellows worldwide have been elected, of which only 15 are Canadian.
Over $3 trillion in revenue has been generated based on NAI Fellow discoveries.
CEO Dr. Lyle Oberg is thrilled to see one of his own achieve new levels of success and continues to look forward to what awaits the company.
“Dr. Jefferies is strongly focused on advancing [Mynd’s] clinical developments for both the biomarker diagnostic division and our new drug development candidates.”
MYND Life Sciences Inc. is a medical biotech drug research and development company focused on neuro-pharmaceutical and novel psilocybin drug development and diagnostics.
Mynd Life Sciences Inc. (MYND) is in the grey, trading at C$0.06 at 11:34 am EST.
